Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07527858) titled 'Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer' on April 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Gilead Sciences
Condition:
Advanced Microsatellite Stable Colorectal Cancer
Intervention:
Drug: Denikitug
Drug: Nivolumab
Drug: Bevacizumab
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 2026
Target Sample Size: 170
To know more, visit https://clinicaltrials....